NCT02857361View on ClinicalTrials.gov

Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Pain
Interventions
DRUG

Sublingual ketamine wafers

Two sublingual ketamine 25 mg wafers

Trial Locations (1)

6009

Linear Clinical Research, Nedlands

All Listed Sponsors
lead

iX Biopharma Ltd.

OTHER

NCT02857361 - Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols. | Biotech Hunter | Biotech Hunter